Molecular Predictors of Pemetrexed and Carboplatin Response in Malignant Pleural Mesothelioma (MPM) Patients
NCT00867711 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 121
Last updated 2014-12-02
Summary
The aim of the present study is to investigate the molecular predictors of pemetrexed and carboplatin response in tumor samples of a series of MPM patients extracting the DNA and genotyping for the TSER polymorphism.
Conditions
- MALIGNANT PLEURAL MESOTHELIOMA
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Principal Investigators
-
Armando Santoro, MD · Istituto Clinico Humanitas
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-01-31
- Primary Completion
- 2011-12-31
- Completion
- 2011-12-31
Countries
- Italy
Study Locations
More Related Trials
-
Pemetrexed in Advanced Non-small Cell Lung Cancer
NCT01193959 ·Status: COMPLETED
-
Carboplatin, Bevacizumab and Pemetrexed in the First-Line Treatment of Patients With Malignant Pleural Mesothelioma (MPM)
NCT00604461 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
A Study of Tiragolumab in Combination With Atezolizumab Plus Pemetrexed and Carboplatin/Cisplatin Versus Pembrolizumab Plus Pemetrexed and Carboplatin/Cisplatin in Participants With Previously Untreated Advanced Non-Squamous Non-Small Cell Lung Cancer
NCT04619797 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of Atezolizumab in Combination With Carboplatin Plus (+) Nab-Paclitaxel Compared With Carboplatin+Nab-Paclitaxel in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)
NCT02367781 ·Status: COMPLETED ·Phase: PHASE3
-
Pemetrexed Disodium and Carboplatin in Treating Patients With Extensive-Stage Small Cell Lung Cancer
NCT00227565 ·Status: COMPLETED ·Phase: PHASE2
-
Pleurectomy/ Decortication (P/D) Preceded or Followed by Chemotherapy in Patients With Early Stage MPM
NCT02436733 ·Status: UNKNOWN ·Phase: PHASE2
-
Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
NCT00520676 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
NCT02259582 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of CRS-207 With Pembrolizumab in Previously Treated Malignant Pleural Mesothelioma (MPM)
NCT03175172 ·Status: TERMINATED ·Phase: PHASE2
-
Tumor Response to Pemetrexed Disodium in Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Enrolled in Clinical Trial MCCRC-RC0524
NCT00898820 ·Status: COMPLETED
-
Pemetrexed-free vs. Pemetrexed-based Immunochemotherapy in Metastatic TTF-1 Negative Lung Adenocarcinoma
NCT05689671 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
OT-101 in Combination With Pembrolizumab in Subjects With Malignant Pleural Mesothelioma Failing to Respond to Checkpoint Inhibition
NCT05425576 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer
NCT01527864 ·Status: UNKNOWN ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration
NCT05253807 ·Status: COMPLETED ·Phase: PHASE2
-
MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma
NCT06097728 ·Status: RECRUITING ·Phase: PHASE3
-
A Study of Atezolizumab in Combination With Carboplatin + Paclitaxel or Carboplatin + Nab-Paclitaxel Compared With Carboplatin + Nab-Paclitaxel in Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower131]
NCT02367794 ·Status: COMPLETED ·Phase: PHASE3
-
Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the Pleura
NCT00019825 ·Status: COMPLETED ·Phase: PHASE1
-
Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer
NCT03713944 ·Status: TERMINATED ·Phase: PHASE2
-
Clinical Trial of Tumor Cell-derived Microparticles Packaging Chemotherapeutic Drugs to Treat Malignant Pleural Effusion
NCT02657460 ·Status: UNKNOWN ·Phase: PHASE2
-
Study of the Combination of Tivantinib Plus Pemetrexed and Carboplatin
NCT02049060 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Pemetrexed/Carboplatin vs Vinorelbine/Carboplatin in Patients With Completely Resected Non-small Cell Lung Cancer (NSCLC)
NCT01258127 ·Status: UNKNOWN
-
Atezolizumab in Combination With Carboplatin Plus Pemetrexed in Chemotherapy-naïve Patients With Asymptomatic Brain Metastasis
NCT03526900 ·Status: COMPLETED ·Phase: PHASE2
-
Phase 1b/2 Trial of AMG386 With Pemetrexed and Carboplatin in Non-Small Cell Lung Cancer
NCT01666977 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Panitumumab Plus Pemetrexed and Cisplatin (PemCisP) Versus PemCis in the First-line Treatment of Patients With Non-small Cell Lung Cancer
NCT01088620 ·Status: SUSPENDED ·Phase: PHASE2
-
Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM)
NCT03760575 ·Status: RECRUITING ·Phase: PHASE1